Dr. Nagourney's Blog


Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

Every Cancer Patient Outcome is Important - Stage 4 Stomach Cancer
By Robert A. Nagourney, MD
Clinical oncologists can be divided into different camps. There are those who see patient outcomes as a means-to-an-end. Each clinical response provides a data point and when those data points reach critical mass they become reportable. These...
Triple Negative Breast Cancer - Worse or Just Different?
By Robert A. Nagourney, MD
The term “triple negative breast cancer” (TNBC) is applied to a subtype of breast cancers that do not express the estrogen or...
The Avastin Saga Continues
By Robert A. Nagourney, MD
We previously wrote about bevacizumab (Avastin) and its approval for breast cancer. The early clinical trials revealed evidence...
The Role of the Platinum Derivatives in Cancer Therapy
By Robert A. Nagourney, MD
The discovery of cisplatinum and the subsequent development of its derivatives (carboplatin and oxaliplatin) represent an...
What Can We Offer Patients For Pancreatic Cancer Survival?
By Robert A. Nagourney, MD
Recently, I received a call from a previous patient for whom I was not the treating oncologist. Originally, she had heard about...

browse by topic

Select A topic

View All Topics

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.